BioNote, Inc. (KRX:377740)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,820.00
+20.00 (0.34%)
At close: Oct 2, 2025
0.34%
Market Cap587.90B
Revenue (ttm)112.04B
Net Income (ttm)120.16B
Shares Out101.36M
EPS (ttm)1,182.12
PE Ratio4.91
Forward PEn/a
Dividend200.00 (3.45%)
Ex-Dividend Daten/a
Volume59,232
Average Volume81,705
Open5,900.00
Previous Close5,800.00
Day's Range5,500.00 - 5,900.00
52-Week Range4,150.00 - 6,320.00
Beta1.02
RSI46.57
Earnings DateNov 14, 2025

About BioNote

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwa... [Read more]

Sector Healthcare
Founded 2003
Employees 298
Stock Exchange Korea Stock Exchange
Ticker Symbol 377740
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.